Population aging projections across the US show a divide between cities and rural areas, which could lead to pockets of vulnerability to climate change.

Long before symptoms like memory loss even emerge, the underlying pathology of Alzheimer’s disease, such as an accumulation of amyloid protein plaques, is well underway in the brain.

A home-cooked meal has many benefits, including healthier ingredients and fewer processed foods. 

Liver cancer is the second leading cause of cancer-related deaths worldwide. The most common primary liver cancer in adults is known as hepatocellular carcinoma (HCC), and accounts for approximately 780,000 deaths every year.

A new study from Washington University School of Medicine in St. Louis sheds light on how human gut microbes break down processed foods — especially potentially harmful chemical changes often produced during modern food manufacturing processes.

The growing appetite for animal protein in developing countries has resulted in a smorgasbord of antibiotic consumption for livestock that has nearly tripled the occurrence of antibiotic resistance in disease-causing bacteria easily transmitted from animals to humans, according to a recent report in the journal Science.

Patients with advanced melanoma have been able to live longer because of several newly approved targeted treatment options, including BRAF and MEK inhibitors.

A new study by chemists at the University of Arkansas shows that X-ray crystallography, the standard method for determining the structure of proteins, can provide inaccurate information about a critical set of proteins – those found in cell membranes – which in turn could be leading to poor and inefficient drug design.

Brown University researchers, surgeons from Rhode Island Hospital and private partners will develop and test a device aimed at bridging the gap in neural circuitry created by spinal cord injury, in the hope of restoring muscle control and sensation.

With improved treatments, especially the use of anti-cancer immunotherapies, more than two-thirds of all patients diagnosed with diffuse large B-cell lymphoma (DLBCL) will survive.